Regency Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-110
Closed -$23K 124
2021
Q3
$23K Buy
110
+5
+5% +$1.15K 0.02% 99
2021
Q2
$26K Sell
105
-2
-2% -$492 0.02% 89
2021
Q1
$27K Buy
+107
New +$25.5K 0.03% 102

Other funds holding AMGN

Regency Capital Management's AMGN Position: Q4 2021 in Review

Regency Capital Management sold out of Amgen (AMGN) in Q4 2021, closing a stake of 110 shares — an estimated $23K sold.

Regency Capital Management first reported a position in AMGN in Q1 2021 and held it in 3 quarters. The position peaked at $27K in Q1 2021. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Regency Capital Management reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Regency Capital Management sold 110 Amgen shares in Q4 2021, an estimated $23K.
  • Regency Capital Management first reported a position in Amgen in Q1 2021 and held it in 3 quarters.
  • Regency Capital Management's Amgen position peaked at $27K in Q1 2021.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Regency Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.